Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer

  1. Kim, S.-B.
  2. Wildiers, H.
  3. Krop, I.E.
  4. Smitt, M.
  5. Yu, R.
  6. Lysbet de Haas, S.
  7. Gonzalez-Martin, A.
Journal:
International Journal of Cancer

ISSN: 1097-0215,  0020-7136

Year of publication: 2016

Volume: 139

Issue: 10

Pages: 2336-2342

Type: Article

DOI: 10.1002/IJC.30276 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus